Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorNanjing First Hospital, Nanjing Medical University
About this trial
This registry aimed to investigate drug-coated balloon procedural factors (particularly delivery time and inflation duration) to evaluate the impact on angiographic and clinical outcomes in patients undergoing percutaneous coronary intervention for de novo coronary lesions.
Eligibility criteria
Qualifiers
Age ≥18 years
Stable coronary artery disease or unstable angina
De novo coronary lesion (reference vessel diameter 2.25-4.0 mm; lesion length ≤40 mm)
Planned DCB strategy for PCI
Disqualifiers
Acute myocardial infarction within 72 hours
Severe heart failure (NYHA class IV)
Severe hepatic or renal insufficiency
Allergy to drug-coated balloon components or antiplatelet agents, or intolerance to dual antiplatelet therapy
Trial design
Treatments tested in this trial
- Not listed
Trial groups
500 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov